UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 214

Sortiert nach

Diffuse Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Predictors of Respiratory Failure and Clinical Outcomes

Arthritis & rheumatology (Hoboken, N.J.), 2016-06, Vol.68 (6), p.1467-1476

2016

Volltextzugriff (PDF)

Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3

Arthritis & rheumatology (Hoboken, N.J.), 2016-07, Vol.68 (7), p.1700-1710

2016

Volltextzugriff (PDF)

Pulmonary Complications of Portal Hypertension

Clinics in liver disease, 2019-11, Vol.23 (4), p.683-711

2019

Volltextzugriff (PDF)

Randomized Clinical Trial of a Combination of an Inhaled Corticosteroid and Beta Agonist in Patients at Risk of Developing the Acute Respiratory Distress Syndrome

Critical care medicine, 2017-05, Vol.45 (5), p.798-805

2017

Volltextzugriff (PDF)

Safety and Efficacy of Ambrisentan for the Treatment of Portopulmonary Hypertension

Chest, 2011, Vol.139 (1), p.109-114

2011

Volltextzugriff (PDF)

Primary Antiphospholipid Syndrome–Associated Diffuse Alveolar Hemorrhage

Arthritis care & research (2010), 2014-02, Vol.66 (2), p.301-310

2014

Volltextzugriff (PDF)

The Pharmacogenomic Association of Fcγ Receptors and Cytochrome P450 Enzymes With Response to Rituximab or Cyclophosphamide Treatment in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

Arthritis & rheumatology (Hoboken, N.J.), 2017-01, Vol.69 (1), p.169-175

2017

Volltextzugriff (PDF)

Relationship between portopulmonary hypertension and splenectomy: Mayo Clinic experience and review of published works

Hepatology research, 2018-02, Vol.48 (3), p.E340-E346

2018

Volltextzugriff (PDF)

Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT-1/-2 studies

Pulmonary circulation, 2018-04, Vol.8 (2), p.1-4

2018

Volltextzugriff (PDF)

Pulmonary Arteriovenous Malformations

Chest, 2013-09, Vol.144 (3), p.1033-1044

2013

Volltextzugriff (PDF)

Outcomes of Severe Sepsis and Septic Shock Patients on Chronic Antiplatelet Treatment: A Historical Cohort Study

Critical Care Research and Practice, 2013-01, Vol.2013, p.782573-9

2013

Volltextzugriff (PDF)

Predictors of Acute Kidney Injury in Septic Shock Patients: An Observational Cohort Study

Clinical journal of the American Society of Nephrology, 2011-07, Vol.6 (7), p.1744-1751

2011

Volltextzugriff (PDF)

Hepatopulmonary syndrome: Favorable outcomes in the MELD exception era

Hepatology (Baltimore, Md.), 2013-06, Vol.57 (6), p.2427-2435

2013

Volltextzugriff (PDF)

Diarrhea during critical illness: a multicenter cohort study

Intensive care medicine, 2022-05, Vol.48 (5), p.570-579

2022

Volltextzugriff (PDF)

Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia–Related Epistaxis and Gastrointestinal Bleeding

Mayo Clinic proceedings, 2018-02, Vol.93 (2), p.155-166

2018

Volltextzugriff (PDF)

Epidemiology of Acute Respiratory Distress Syndrome Following Hematopoietic Stem Cell Transplantation

Critical care medicine, 2016-06, Vol.44 (6), p.1082-1090

2016

Volltextzugriff (PDF)

Long‐Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis

Arthritis care & research (2010), 2021-09, Vol.73 (9), p.1372-1378

2021

Volltextzugriff (PDF)

Topic-Based, Recent Literature Review on Pulmonary Hypertension

Mayo Clinic proceedings, 2021-12, Vol.96 (12), p.3109-3121

2021

Volltextzugriff (PDF)

Clinical characteristics of inflammatory ocular disease in anti-neutrophil cytoplasmic antibody associated vasculitis: a retrospective cohort study

Rheumatology (Oxford, England), 2017-10, Vol.56 (10), p.1763-1770

2017

Volltextzugriff (PDF)

Experience with rituximab in the treatment of antineutrophil cytoplasmic antibody associated vasculitis

Therapeutic Advances in Musculoskeletal Disease, 2014-04, Vol.6 (2), p.58-74

2014

Volltextzugriff (PDF)

Pleuritis and Pericarditis in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis

Chest, 2021-08, Vol.160 (2), p.572-581

2021

Volltextzugriff (PDF)

Biopsy-proven pulmonary capillaritis: A retrospective study of aetiologies including an in-depth look at isolated pulmonary capillaritis

Respirology (Carlton, Vic.), 2016-05, Vol.21 (4), p.734-738

2016

Volltextzugriff (PDF)

Intrapulmonary vascular dilatations are common in portopulmonary hypertension and may be associated with decreased survival

Liver transplantation, 2015-11, Vol.21 (11), p.1355-1364

2015

Volltextzugriff (PDF)

Low baseline serum creatinine concentration predicts mortality in critically ill patients independent of body mass index

Critical care medicine, 2007-10, Vol.35 (10), p.2420-2423

2007

Volltextzugriff (PDF)

Trends in the Incidence and Outcomes of Disseminated Intravascular Coagulation in Critically Ill Patients (2004-2010)

Chest, 2013-05, Vol.143 (5), p.1235-1242

2013

Volltextzugriff (PDF)

1 – 25 von 214

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(196)
Mit Volltextzugriff
(199)

Publikationsform

Sprache

Englisch
(214)
Japanisch
(21)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Diffuse Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Predictors of Respiratory Failure and Clinical Outcomes

Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3

Pulmonary Complications of Portal Hypertension

Randomized Clinical Trial of a Combination of an Inhaled Corticosteroid and Beta Agonist in Patients at Risk of Developing the Acute Respiratory Distress Syndrome

Safety and Efficacy of Ambrisentan for the Treatment of Portopulmonary Hypertension

Primary Antiphospholipid Syndrome–Associated Diffuse Alveolar Hemorrhage

The Pharmacogenomic Association of Fcγ Receptors and Cytochrome P450 Enzymes With Response to Rituximab or Cyclophosphamide Treatment in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

Relationship between portopulmonary hypertension and splenectomy: Mayo Clinic experience and review of published works

Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT-1/-2 studies

Pulmonary Arteriovenous Malformations

Outcomes of Severe Sepsis and Septic Shock Patients on Chronic Antiplatelet Treatment: A Historical Cohort Study

Predictors of Acute Kidney Injury in Septic Shock Patients: An Observational Cohort Study

Hepatopulmonary syndrome: Favorable outcomes in the MELD exception era

Diarrhea during critical illness: a multicenter cohort study

Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia–Related Epistaxis and Gastrointestinal Bleeding

Epidemiology of Acute Respiratory Distress Syndrome Following Hematopoietic Stem Cell Transplantation

Long‐Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis

Topic-Based, Recent Literature Review on Pulmonary Hypertension

Clinical characteristics of inflammatory ocular disease in anti-neutrophil cytoplasmic antibody associated vasculitis: a retrospective cohort study

Experience with rituximab in the treatment of antineutrophil cytoplasmic antibody associated vasculitis

Pleuritis and Pericarditis in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis

Biopsy-proven pulmonary capillaritis: A retrospective study of aetiologies including an in-depth look at isolated pulmonary capillaritis

Intrapulmonary vascular dilatations are common in portopulmonary hypertension and may be associated with decreased survival

Low baseline serum creatinine concentration predicts mortality in critically ill patients independent of body mass index

Trends in the Incidence and Outcomes of Disseminated Intravascular Coagulation in Critically Ill Patients (2004-2010)

Suchergebnisse filtern